0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

ASEPTIC IRRITATIVE PHLEBITIS FOLLOWING INTRAVENOUS INJECTION OF SODIUM SALT OF TETRABROMPHENOLPHTHALEIN

Frank Smithies, M.D.; Richard Bartlett Oleson, M.D.
JAMA. 1925;84(20):1494-1495. doi:10.1001/jama.1925.26620460004012b.
Text Size: A A A
Published online

On the publication of Drs. Graham and Cole1 of their method of intravenous injection of the calcium salt of tetrabromphenolphthalein in order to develop a biliary tract opacity for roentgenographic observation, we tested the procedure and reported a series of cases.2 Our observations corroborated their findings. In our report we stated that we had seen no evidences of toxicity in the employment of the calcium salt and, indeed, our later practice would not cause us to alter this statement so far as the calcium salt is concerned. When, however, in accordance with the more recent suggestion of Graham and Cole,3 we used the sodium salt of tetrabromphenolphthalein, we encountered two patients who responded in so unsatisfactory a manner and caused us so much anxiety throughout their clinical courses that we have thought it advisable to report our experience.

REPORT OF CASES 

Case 1.  —In the spring of

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();